| www.nextgensciences.com | |
|
PRESS RELEASE: 8th June 2006
Dr Geoff Alms joins NextGen Science Inc. from Upstate Inc., a Division of Serologicals Corporation, where he was employed as Director of Sales for Drug Discovery, North America. While there, he drove the sales growth in the first six months post-acquisition and integration by over 55% and retained 100% of employees during the post-sale integration of the company. During his employment at Upstate, Geoff formed and led the drug discovery sales team, resulting in rapid revenue growth. He has negotiated the successful completion of more than 30 major contracts. Prior to his sales leadership at Upstate, Geoff completed his Ph.D. and postdoctoral studies in Pharmacology at the University of Virginia. Geoff first applied that scientific background to lead the business development efforts at Upstate. He commented that “I discovered NextGen Sciences while in the role of business development for Upstate six years ago. Having watched its development over that time with interest, I am pleased to have joined NextGen and to be leading its sales activities in introducing the Group’s integrated technologies into the US market.” Geoff’s appointment along with 3 experienced salesmen completes the initial phase in the formation of a technically qualified sales team in the USA focussed on the commercialisation of NextGen’s main gene to protein product range which includes the Expression Workstation, a2DEoptimizer, OrchestratorIMS and the newly introduced ContractExpress fee for service business. Gareth Thomson joins NextGen Group PLC as Head of Marketing from Affymetrix UK Ltd, where he was employed as the Senior Marketing Manager. He has over 10 years experience in marketing and was responsible for the development and implementation of a regional marketing plan that included direct marketing campaigns, product launches and media placement. He successfully launched over 30 new products and has negotiated Global Supply Contracts with several major Pharmaceutical companies. Prior to this he worked for Amersham-Pharmacia Biotech, now GE Healthcare, where he was responsible for major account management including Glaxo SmithKline and a number of academic institutes. He holds a B.Sc. in Biological Sciences from Salford University in Manchester. Commenting on these appointments Dr James Heffernan, CEO of NextGen Group PLC said “Geoff and I previously worked together at Upstate Inc. and I have always been impressed by his commercial acumen and technical knowledge as well as his ability to develop and motivate people. I was delighted when I first heard about Geoff’s application to join Nextgen as he has the ideal background to drive our commercialisation process in the important US market. The appointment of Gareth enhances our ability to expand our global marketing activities. His career to-date shows that he is results orientated and has the necessary experience to drive forward the marketing of our existing range of products and services and prepare the market for the new products we intend to introduce.”
Mike
Wort, Anna Dunphy The commercial alliance with PRS was the first significant step in that process giving NextGen access to expertise, a USA based infrastructure, additional products and facilities. This appointment and the creation of a dedicated NextGen Inc. Sales and Marketing team will complete the first phase of the commercialization of NextGen products and services in North America. Further
details relating to NextGen Group PLC and its products can be found
at www.nextgensciences.com |
|
|
If you can’t open this electronic message, visit www.nextgensciences.com |
|
|
© NextGen Sciences Ltd 2006, All rights
reserved |
|
